Form 8-K - Current report:
SEC Accession No. 0001104659-22-041035
Filing Date
2022-03-31
Accepted
2022-03-31 16:13:26
Documents
12
Period of Report
2022-03-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2210916d1_8k.htm   iXBRL 8-K 29303
  Complete submission text file 0001104659-22-041035.txt   205648

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ptgx-20220325.xsd EX-101.SCH 3054
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptgx-20220325_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptgx-20220325_pre.xml EX-101.PRE 22609
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2210916d1_8k_htm.xml XML 3745
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

EIN.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37852 | Film No.: 22792642
SIC: 2834 Pharmaceutical Preparations